T and B lymphocytes, immunoglobulins and complement components in bronchial asthma. 1978

J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma

Sixty children, 7--15 years old, suffering from bronchial asthma and 44 healthy children, 12--14 years old, were studied for the percentage and the total count per mm.3 of T and B lymphocytes. Patients were classified into extrinsic atopic, mixed and intrinsic asthma. According to the clinical course mild and severe cases were analysed separately. The total and "active" T lymphocytes were detected by the ability to form nonimmune rosettes with sheep red blood cells. The B lymphocytes were estimated by the rosetting procedure with antibody mouse complement coated sheep erythrocytes. No decrease of the percentage or total count of T lymphocytes was observed, and an elevation of total count and percentage of active T cell rosettes was even seen in severe cases of extrinsic atopic asthma. The B cell percentage was decreased in severe atopic, mild intrinsic and mild mixed asthma but the total number was lowered only in the last group. The immunoglobulin A, G, M, D and E level, measured by the single radial immunodifussion test, was correlated neither to T cell nor B cell percentage. The complement components C1q, C4, C3, C3 proactivator and C5 were measured by the radial immunodufusion test in the plasma of some patients and controls. The C1q level was normal. An elevation of C4 in mild extrinsic, C5 in severe extrinsic and C3 in severe mixed asthma was seen. A decrease of C3 proactivator was observed in mild extrinsic and mixed asthma, and in three cases of intinsic asthma this was accompanied by lowering of C3, suggesting an activation of the alternative pathway.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
October 1974, Lancet (London, England),
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
December 1976, Clinical and experimental immunology,
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
October 1989, Annals of allergy,
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
January 1987, Folia medica Cracoviensia,
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
January 1988, The Indian journal of chest diseases & allied sciences,
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
January 1985, Polski tygodnik lekarski (Warsaw, Poland : 1960),
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
January 1980, Allergologia et immunopathologia,
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
February 1973, Alergia,
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
August 1971, Revista clinica espanola,
J Pryjma, and A Sciślicki, and B Rusinek, and K Pryjma
April 1977, Harefuah,
Copied contents to your clipboard!